JACQUELINE CORRIGAN-CURAY was selected as the permanent director of the FDA Office of Medical Policy at the Center for Drug Evaluation and Research. Corrigan-Curay most recently served as a supervisory medical officer with the Immediate Office of the Director at NIH’s National Heart, Lung, and Blood Institute, where she worked on establishing a new trans-NHLBI...
The first large cancer screening/early detection initiative to be launched in 2025—the NCI-funded Vanguard study of multi-cancer detection tests—has started accruing patients through nine sites across the U.S.
